序号 |
标题 |
次数 |
作者 |
发布时间 |
70876 |
黄芩苷脂质体,Baicalin Liposome |
193 |
axc |
2024-12-25 |
70877 |
mPEG11-SH,甲氧基十一聚乙二醇-巯基 |
69 |
wyh |
2024-12-25 |
70878 |
Ald-Ph-amido-PEG2-C2-Pfp ester,2101206-60-2,ADC试剂 |
71 |
hyy |
2024-12-25 |
70879 |
芹菜素脂质体,Apigenin Liposome |
94 |
axc |
2024-12-25 |
70880 |
5-[4-(3,5-二-十二烷氧基苯甲酰亚胺基)苯基]-10,15,20-三苯基卟啉配体(DDTPP) |
75 |
WYQ |
2024-12-25 |
70881 |
mPEG10-OCH2CH2COOH的应用领域 |
65 |
wyh |
2024-12-25 |
70882 |
Methyltetrazine-CH2NHCO-PEG5-CH2CH2NHBoc的结构式 |
85 |
zyl |
2024-12-25 |
70883 |
Meso-四(4-十四氨基甲酰苯基)卟啉(14AFPP) |
93 |
WYQ |
2024-12-25 |
70884 |
雷公藤内酯醇脂质体(聚乙二醇化),Triptolide Liposome (PEGylated) |
88 |
axc |
2024-12-25 |
70885 |
Methyltetrazine-CH2NHCO-PEG11-CH2CH2COOH的结构式 |
84 |
zyl |
2024-12-25 |
70886 |
Meso-5,10,15,20-四(对氯苯基)卟啉;TP-ClPPH2 |
107 |
WYQ |
2024-12-25 |
70887 |
Resveratrol Liposome 白藜芦醇脂质体 |
219 |
axc |
2024-12-25 |
70888 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
122 |
WYQ |
2024-12-25 |
70889 |
Methyltetrazine-CH2NHCO-PEG6-CH2CH2COOH |
116 |
zyl |
2024-12-25 |
70890 |
ld-Ph-amido-PEG1-C2-NHS ester, 2101206-80-6,抗体- 药物偶联物 |
79 |
hyy |
2024-12-25 |
70891 |
cas:1807521-07-8,2,5-dioxopyrrolidin-1-yl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate |
66 |
h |
2024-12-25 |
70892 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
97 |
WYQ |
2024-12-25 |
70893 |
Methyltetrazine-CH2NHCO-PEG11-CH2-C≡CH的结构式 |
73 |
zyl |
2024-12-25 |
70894 |
cas:126695-58-7,4-Azido-2,3,5,6-tetrafluorobenzoic Acid N-Succinimidyl ester |
68 |
h |
2024-12-25 |
70895 |
5,10,15,20-四-(对-十二酰氧基)苯基卟啉 (TLPPH2) |
75 |
WYQ |
2024-12-25 |
70896 |
cas:850180-76-6,3-azidopropanoate-N-hydroxysuccinimide ester |
89 |
h |
2024-12-25 |
70897 |
Methyltetrazine-CH2NHCO-PEG6-CH2-C≡CH的介绍 |
106 |
zyl |
2024-12-25 |
70898 |
cas:906564-59-8,5-Hexynoic Acid-NHS Ester |
77 |
h |
2024-12-25 |
70899 |
mPEG5-OCH2CH2COOH;甲氧基五聚乙二醇丙酸 |
122 |
wyh |
2024-12-25 |
70900 |
5-[4-(3,5-二-十二烷氧基苯甲酰亚胺基)苯基]-10,15,20-三苯基卟啉配体(DDTPP) |
76 |
WYQ |
2024-12-25 |
70901 |
cas:55750-62-4,3-(Maleimido)propionic acid N-hydroxysuccinimide ester |
121 |
h |
2024-12-25 |
70902 |
Meso-四(4-十四氨基甲酰苯基)卟啉(14AFPP) |
83 |
WYQ |
2024-12-25 |
70903 |
mPEG12-OH , 甲氧基十二聚乙二醇-羟基 |
111 |
wyh |
2024-12-25 |
70904 |
cas:1305053-43-3,15-(2-pyridyldithio)-4,7,10,13-tetraoxapentadecanoic acid N-hydroxysuccinimide ester |
65 |
h |
2024-12-25 |
70905 |
4-甲酰苯甲酸N-琥珀酰亚胺酯,60444-78-2,ADC试剂 |
97 |
hyy |
2024-12-25 |
70906 |
Meso-5,10,15,20-四(对氯苯基)卟啉;TP-ClPPH2 |
100 |
WYQ |
2024-12-25 |
70907 |
cas:317331‐86‐5,N-succinimidyl-5-(2-pyridyldithio)valerate |
72 |
h |
2024-12-25 |
70908 |
cas:663599-11-9,1-(4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
95 |
h |
2024-12-25 |
70909 |
mPEG7-NH2,甲氧基七聚乙二醇-氨基 |
114 |
wyh |
2024-12-25 |
70910 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
118 |
WYQ |
2024-12-25 |
70911 |
N3-PEG4-C2-Pfp ester,1353012-00-6,抗体- 药物偶联物 |
68 |
hyy |
2024-12-25 |
70912 |
cas:341498-08-6,N-Succinimidyl 4-(2-pyridyldithio)pentanoate |
93 |
h |
2024-12-25 |
70913 |
mPEG16-NH2 ,cas:907577-50-8 ,甲氧基十六聚乙二醇-氨基 |
102 |
wyh |
2024-12-25 |
70914 |
cas:115088-06-7,N-Succinimidyl 4-(2-pyridyldithio)butanoate |
98 |
h |
2024-12-25 |
70915 |
mPEG48-Br,甲氧基四十八聚乙二醇溴代 |
78 |
wyh |
2024-12-25 |
70916 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
100 |
WYQ |
2024-12-25 |
70917 |
mPEG11-Br,溴代十一甘醇单甲醚 |
67 |
wyh |
2024-12-25 |
70918 |
NHS-PEG4-azide,叠氮-PEG4-NHS酯,944251-24-5 ,ADC试剂 |
79 |
hyy |
2024-12-25 |
70919 |
cas:1610769-13-5,4-((S)-2-((S)-2-amino-3- methylbutanamido)-5- ureidopentanamido)benzyl 2-(pyridin- 2-yldisulfanyl)ethylcarbamate |
89 |
h |
2024-12-25 |
70920 |
mPEG4-OCH2COOH的结构特点,16024-66-1 |
100 |
wyh |
2024-12-25 |